RefleXion Medical Radiotherapy System (RMRS)
DEN220014 is the FDA 510(k) clearance record for RefleXion Medical Radiotherapy System (RMRS), a class II device, cleared for Reflexion Medical, Inc. on under FDA product code QVA (Fludeoxyglucose F18-Guided Radiation Therapy System). FDA's definition for product code QVA reads: "A fludeoxyglucose F18-guided radiation therapy system is a device that combines the functionality of an emission computed tomography detection system and a linear accelerator. The device is intended for use with approved fludeoxyglucose...". FDA records list 3 510(k) clearances for Reflexion Medical, Inc., from to . As of , FDA records show no recalls naming DEN220014.
Clearance record
- Decision date
- Received
- (343 days to decision)
- Product code
- QVA Fludeoxyglucose F18-Guided Radiation Therapy System
- Regulation
- 21 CFR 892.5060
- Device class
- Class II
- Review panel
- Radiology
- Applicant
- Reflexion Medical, Inc. 25841 Industrial Blvd., Suite 275, Hayward CA
- Third party review
- No
Clearances, product code QVA
Trailing 12 monthsShow the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 1 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
